title: Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
authors.affiliation: Biomeasure Incorporated, Hopkinton, Massachusetts 07148.
authors.forename: A E
authors.initials: AE
authors.lastname: Bogden
authors.forename: P
authors.initials: P
authors.lastname: Carde
authors.forename: E D
authors.initials: ED
authors.lastname: de Paillette
authors.forename: J P
authors.initials: JP
authors.lastname: Moreau
authors.forename: M
authors.initials: M
authors.lastname: Tubiana
authors.forename: E
authors.initials: E
authors.lastname: Frindel
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002460:Cell Line; D003520:Cyclophosphamide / Q000627:therapeutic use / Q000633:toxicity*; D003561:Cytarabine / Q000494:pharmacology / Q000633:toxicity*; D005260:Female; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000503:physiopathology; D008175:Lung Neoplasms / Q000188:drug therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use*; D014183:Transplantation, Heterologous
chemical_list: D006131:Growth Inhibitors; D009842:Oligopeptides; D003561:Cytarabine; D003520:Cyclophosphamide; C058504:goralatide